BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mullath A, Krishna M. Hepatocellular carcinoma – time to take the ticket. World J Gastrointest Surg 2019; 11(6): 287-295 [PMID: 31367276 DOI: 10.4240/wjgs.v11.i6.287] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Sun S, Gao J, Zhou S, Li Y, Wang Y, Jin L, Li J, Liu B, Zhang B, Han S, Ding H, Li X. A novel circular RNA circ-LRIG3 facilitates the malignant progression of hepatocellular carcinoma by modulating the EZH2/STAT3 signaling. J Exp Clin Cancer Res 2020;39:252. [PMID: 33222697 DOI: 10.1186/s13046-020-01779-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
2 An Y, Wang Q, Zhang G, Sun F, Zhang L, Li H, Li Y, Peng Y, Zhu W, Ji S, Guo X. OSlihc: An Online Prognostic Biomarker Analysis Tool for Hepatocellular Carcinoma. Front Pharmacol 2020;11:875. [PMID: 32587519 DOI: 10.3389/fphar.2020.00875] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Tang T, Tao X, Bao X, Chen J, Dai J, Ye J, Yan Y. Mitofusin-2 (Mfn-2) Might Have Anti-Cancer Effect through Interaction with Transcriptional Factor SP1 and Consequent Regulation on Phosphatidylinositol Transfer Protein 3 (PITPNM3) Expression. Med Sci Monit 2020;26:e918599. [PMID: 31955176 DOI: 10.12659/MSM.918599] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]